ZA974266B - Anti-vaginitis compositions for topical use - Google Patents

Anti-vaginitis compositions for topical use

Info

Publication number
ZA974266B
ZA974266B ZA974266A ZA974266A ZA974266B ZA 974266 B ZA974266 B ZA 974266B ZA 974266 A ZA974266 A ZA 974266A ZA 974266 A ZA974266 A ZA 974266A ZA 974266 B ZA974266 B ZA 974266B
Authority
ZA
South Africa
Prior art keywords
vaginitis
compositions
topical use
topical
vaginitis compositions
Prior art date
Application number
ZA974266A
Inventor
Koral Embil
Oswald Morton
Original Assignee
Edko Trading Representation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10793879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA974266(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Edko Trading Representation filed Critical Edko Trading Representation
Publication of ZA974266B publication Critical patent/ZA974266B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA974266A 1996-05-17 1997-05-16 Anti-vaginitis compositions for topical use ZA974266B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9610359.3A GB9610359D0 (en) 1996-05-17 1996-05-17 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA974266B true ZA974266B (en) 1998-11-16

Family

ID=10793879

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA974266A ZA974266B (en) 1996-05-17 1997-05-16 Anti-vaginitis compositions for topical use

Country Status (12)

Country Link
EP (1) EP0910377A1 (en)
JP (1) JP2000513334A (en)
CN (1) CN1127338C (en)
AU (1) AU2905597A (en)
BR (1) BR9709316A (en)
GB (1) GB9610359D0 (en)
ID (1) ID16929A (en)
MY (1) MY127711A (en)
RU (1) RU2195281C2 (en)
TR (1) TR199802351T2 (en)
WO (1) WO1997044032A1 (en)
ZA (1) ZA974266B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777783A1 (en) * 1998-04-24 1999-10-29 Innothera Lab Sa Pharmaceutical composition for treatment of infectious vulvovaginitis and vaginosis
US5993836A (en) * 1998-04-28 1999-11-30 Castillo; James G. Topical anesthetic formulation
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
EP1667619A4 (en) 2003-09-19 2007-10-10 Drugtech Corp Pharmaceutical delivery system
US8309103B2 (en) * 2004-01-22 2012-11-13 Alparis, S.A. De C.V. Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
GB0405406D0 (en) * 2004-03-10 2004-04-21 Edko Pazarlama Tanitim Ltd Sti Anti-vaginitis compositions
AU2006244260A1 (en) * 2005-05-09 2006-11-16 Drugtech Corporation Modified-release pharmaceutical compositions
CN1291754C (en) * 2005-07-12 2006-12-27 李赴朝 Localized anesthesia synergistic delay agent
KR20080083190A (en) * 2006-01-05 2008-09-16 드러그테크 코포레이션 Drug delivery system for bioadhesion to a vulvovaginal surface
CA2635986A1 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Composition and method of use thereof
RU2603490C1 (en) * 2015-11-30 2016-11-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Agent for treating pyoinflammatory processes in soft tissues and mucous membranes
RU2605343C1 (en) * 2015-11-30 2016-12-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Agent for treating pyoinflammatory processes in soft tissues and mucous membranes
WO2018007288A1 (en) 2016-07-08 2018-01-11 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Pharmaceutical composition comprising benzydamine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830405D0 (en) * 1988-12-30 1989-03-01 Embil Koral Pharmaceutical formulation

Also Published As

Publication number Publication date
JP2000513334A (en) 2000-10-10
GB9610359D0 (en) 1996-07-24
ID16929A (en) 1997-11-20
BR9709316A (en) 2000-05-02
TR199802351T2 (en) 1999-03-22
RU2195281C2 (en) 2002-12-27
CN1127338C (en) 2003-11-12
EP0910377A1 (en) 1999-04-28
CN1223581A (en) 1999-07-21
WO1997044032A1 (en) 1997-11-27
MY127711A (en) 2006-12-29
AU2905597A (en) 1997-12-09

Similar Documents

Publication Publication Date Title
HK1034663A1 (en) Topical compositions comprising ascorbyl-phosphoryl-cholesterol
GB9600426D0 (en) Compositions
CY2506B1 (en) Composition
PL332118A1 (en) Remineralisable compositions
IL128718A0 (en) Naaldase compositions
IL130330A0 (en) Endo-ectoparasiticidal compositions
GB9601398D0 (en) Composition
ZA975902B (en) Topical composition
ZA974266B (en) Anti-vaginitis compositions for topical use
GB9605247D0 (en) Composition
EP0884044A4 (en) Hairtreatment composition
GB9624540D0 (en) Compositions
GB9600604D0 (en) Composition
GB9620504D0 (en) Compositions
GB9623562D0 (en) Sachet-packaged compositions
GB9602266D0 (en) Composition
HRP970569B1 (en) Fharmaceutical compositions
ZA974126B (en) Topical composition
GB9606901D0 (en) Topical composition
GB9610966D0 (en) Composition
GB9620503D0 (en) Compositions
GB9611365D0 (en) Compositions
GB9604585D0 (en) Composition
GB9600545D0 (en) Compositions
ZA982752B (en) Composition for topical application